West Pharmaceutical Services, Inc. logo WST - West Pharmaceutical Services, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 11
HOLD 3
SELL 1
STRONG
SELL 0
| PRICE TARGET: $372.13 DETAILS
HIGH: $447.00
LOW: $295.00
MEDIAN: $377.50
CONSENSUS: $372.13
UPSIDE: 5.76%

Stock News

Conestoga SMid Cap Composite Q2 2026 Portfolio Review

Conestoga SMid Cap Composite Q2 2026 Portfolio Review

West Pharmaceuticals stock moved higher following another quarter of broad-based growth, driven by continued demand for high-value biologics packaging and proprietary delivery components. Tyler Technologies underperformed during the quarter despite delivering solid financial results that met management's guidance. We were attracted to Knowles' accelerating organic growth, expanding margins, and exposure to several attractive long-term secular trends.

Jul 31, 2026 04:38 AM • seekingalpha.com
West Pharmaceutical Delivers Another Beat - But The Real Story Is The Mix Shift

West Pharmaceutical Delivers Another Beat - But The Real Story Is The Mix Shift

West Pharmaceutical Services delivered a strong 2Q26, beating on both revenue ($872.3M, +13.8% YoY) and EPS ($2.37, +$0.29 vs. consensus). WST raised full-year guidance to $3.345–$3.380B in sales and $8.85–$9.05 in EPS, reflecting confidence in sustained double-digit organic growth and margin expansion. High-Value Product components and biologics drove mix shift, with HVP now 49% of revenue and biologics up 29% organically, supporting durable margin gains.

Jul 24, 2026 04:08 AM • seekingalpha.com

Price Targets